Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 6, 2014, Pages 909-920

  Palmeira Dos Santos, Caroline ^a   Pereira, Gustavo J S ^a   Barbosa, Christiano M V ^a   Jurkiewicz, Aron ^a   Smaili, Soraya S ^a   Bincoletto, Claudia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

3 Methyladenine; AraC; Autophagy; Cell death; Chloroquine; Differentiation; HL60

Indexed keywords

3 METHYLADENINE; CD34 ANTIGEN; CD38 ANTIGEN; CHLOROQUINE; CYTARABINE; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; TRYPAN BLUE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CLONING; CELL DEATH; CELL DIFFERENTIATION; CLONOGENIC ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENINE; ANTIMALARIALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CASPASE 3; CELL PROLIFERATION; CHLOROQUINE; CYTARABINE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; RECEPTORS, RETINOIC ACID; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84901298305     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1640-4     Document Type: Article

References (51)

1. Ablain J, Leiva M, Peres L, Fonsart J, Anthony E, de Thé H (2013) Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. J Exp Med 210:647-653
2. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI et al (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326-336 (Pubitemid 46203961)
3. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W et al (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654-665
4. Arranz R, García-Noblejas A, Grande C, Cannata-Ortiz J, Sánchez JJ, García-Marco JA et al (2013) First line treatment with rituximab-Hyper-CVAD alternating with rituximab- Methotrexate- Cytarabine and followed by consolidation with 90Y-Ibritumomab-Tiuxetan in patients with mantle cell lymphoma. Results of a phase 2 pilot multicenter trial from the GELTA MO group. Haematologica 98:1563-1570
5. Bincoletto C, Bechara A, Pereira GJ, Santos CP, Antunes F, Peixoto da-Silva J et al (2013) Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. Chem Biol Interact 206:279-288
6. Bonvillain RW, Painter RG, Adams DE, Viswanathan A, Lanson NA, Wang G (2010) RNA interference against CFTR affects HL60- derived neutrophil microbicidal function. Free Radic Biol Med 49:1872-1880
7. Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N et al (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025-1040 (Pubitemid 40165810)
8. Buytaert E, Callewaert G, Vandenheede JR, Agostinis P (2006) Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2:238-240 (Pubitemid 44030895)
9. Capizzi RL, Yang JL, Cheng E, Bjornsson T, Sahasrabudhe D, Tan RS et al (1983) Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia. J Clin Oncol 1:763-771 (Pubitemid 14167250)
10. Capizzi RL, Yang JL, Rathmell JP, White JC, Cheng E, Cheng YC et al (1985) Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation. Semin Oncol 12:65-74 (Pubitemid 15063584)
11. Chee LC, Hendy J, Purton LE, McArthur GA (2013) AT RA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells. Leukemia 27:1369-1380
12. Choi KD, Vodyanik M, Slukvin II (2011) Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc 6:296-313
13. Collins SJ, Gallo RC, Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347-349
14. Drexler HG, Quentmeier H, MacLeod RA, Uphoff CC, Hu ZB (1995) Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leuk Res 19:681-691
15. Ekiz HA, Can G, Baran Y (2012) Role of autophagy in the progression and suppression of leukemias. Crit Rev Oncol Hematol 81:275-285
16. Fu S, Consoli U, Hanania EG, Zu Z, Claxton DF, Andreeff M et al (1995) PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells. Clin Cancer Res 1:583-590
17. Giansanti V, Torriglia A, Scovassi AI (2011) Conversation between apoptosis and autophagy: "Is it your turn or mine?". Apoptosis 16:321-333
18. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E et al (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood 83:10-25 (Pubitemid 24016510)
19. Gunji H, Kharbanda S, Kufe D (1991) Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D- arabinofuranosylcytosine. Cancer Res 51:741-743
20. Han C, Sun B, Wang W, Cai W, Lou D, Sun Y et al (2011) Overexpression of microtubule-associated protein-1 light chain 3 is associated with melanoma metastasis and vasculogenic mimicry. Tohoku J Exp Med 223:243-251
21. Janku F, McConkey DJ, Hong DS, Kurzrock R (2011) Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8:528-539
22. Kapuy O, Vinod PK, Mandl J, Bánhegyi G (2013) A cellular stress-directed bistable switch controls the crosstalk between autophagy and apoptosis. Mol BioSyst 9:296-306
23. Koeffler HP (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62:709-721
24. Lamba JK (2011) Pharmacogenomics of cytarabine in childhood leukemia. Pharmacogenomics 12:1629-1632
25. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6:463-477 (Pubitemid 38456176)
26. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27-42
27. Liliemark JO, Plunkett W, Dixon DO (1985) Relationship of 1-beta-Darabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 59-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res 45:5952-5957 (Pubitemid 16218617)
28. Löwenberg B (2013) Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. Blood 121:26-28
29. Lübbert M, Koeffler HP (1988) Myeloid cell lines: tools for studying differentiation of normal and abnormal hematopoietic cells. Blood Rev 2:121-133
30. Major PP, Egan EM, Beardsley GP, Minden MD, Kufe DW (1981) Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA . Proc Natl Acad Sci USA 78:3235-3239 (Pubitemid 11032022)
31. Marone M, Scambia G, Bonanno G, Rutella S, de Ritis D, Guidi F et al (2002) Transforming growth factor-1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects. Leukemia 16:94-105 (Pubitemid 34105604)
32. Mehta K, McQueen T, Neamati N, Collins S, Andreeff M (1996) Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ 7:179-186 (Pubitemid 26049826)
33. Melnick A, Licht JD (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215 (Pubitemid 29220886)
34. Mizushima N (2007) Autophagy: process and function. Genes Dev 21:2861-2873
35. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451:1069-1075 (Pubitemid 351317450)
36. Moon DO, Asami Y, Kim MO, Jang JH, Kim BY, Ahn JS et al (2013) Xestospongin C induces monocytic differentiation of HL60 cells through activation of the ERK pathway. Food Chem Toxicol 55:505-512
37. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 22:927-939 (Pubitemid 41345209)
38. Pelosi E, Castelli G, Martin-Padura I, Bordoni V, Santoro S, Conigliaro A et al (2012) Human haemato-endothelial precursors: cord blood CD34 + cells produce haemogenic endothelium. PLoS ONE 7:e51109
39. Plunkett W, Liliemark JO, Estey E, Keating MJ (1987) Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C. Semin Oncol 14:159-166
40. Raza A, Gezer S, Anderson J, Lykins J, Bennett J, Browman G et al (1992) Relationship of [3H] Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Exp Hematol 20:1194-1200
41. Rustum YM, Raymakers RA (2012) 1-Beta-arabinofuranosylcytosine in therapy of leukemia: preclinical and clinical overview. Pharmacol Ther 56:307-321
42. Saeki K, Yuo A, Okuma E, Yazaki Y, Susin SA, Kroemer G et al (2000) Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ 7:1263-1269 (Pubitemid 32042234)
43. Sasaki K, Tsuno NH, Sunami E, Tsurita G, Kawai K, Okaji Y et al (2010) Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 10:370-375
44. Smaili SS, Hsu YT, Sanders KM, Russell JT, Youle RJ (2001) Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ 8:909-920 (Pubitemid 32782758)
45. Solomon VR, Lee H (2009) Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625:220-233
46. Toksoz D, Bunce CM, Stone PC, Michell RH, Brown G (1982) Variant cell lines from the human promyelocyte line HL60. Leuk Res 6:491-498 (Pubitemid 12001104)
47. Vorbrodt A, Meo P, Rovera G (1979) Regulation of acid phosphatase activity in human promyelocytic leukemic cells induced to differentiate in culture. J Cell Biol 83:300-307 (Pubitemid 10205715)
48. Wang WS, Tzeng CH, Chiou TJ, Liu JH, Hsieh RK, Yen CC et al (1997) High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma. Jpn J Clin Oncol 27:154-157 (Pubitemid 127516323)
49. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281-1292 (Pubitemid 27523214)
50. Yang YP, Liang ZQ, Gao B, Jia YL, Qin ZH (2008) Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. Acta Pharmacol Sin 29:123-134
51. Zayed A, Couban S, Hayne O, Sparavalo N, Shawwa A, Sadek I et al (2007) Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and AT RA resistance. Leuk Lymphoma 48:489-496 (Pubitemid 46487755)